Vaccination against self to prevent autoimmune disease: the type 1 diabetes model FREE

Leonard C Harrison

Immunol Cell Biol (2008) 86: 139-145; doi:10.1038/sj.icb.7100151

Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes FREE

Joseph Torresi, Alex Fischer, Lara Grollo, Weiguang Zeng, Heidi Drummer and David C Jackson

Immunol Cell Biol (2007) 85: 169-173; doi:10.1038/sj.icb.7100021

Induction of protective and therapeutic antitumour immunity using a novel tumour-associated antigen-specific DNA vaccine FREE

Wenxin Sun, Haili Qian, Xueyan Zhang, Chunxia Zhou, Xiao Liang, Dongmei Wang, Ming Fu, Wenbo Ma, Shuren Zhang and Chen Lin

Immunol Cell Biol (2006) 84: 440-447; doi:10.1111/j.1440-1711.2006.01453.x

Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer FREE

Hans-Georg Rammensee

Immunol Cell Biol (2006) 84: 290-294; doi:10.1111/j.1440-1711.2006.01442.x

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys FREE

Jinyan Liu, Kara L. O'Brien, Diana M. Lynch, Nathaniel L. Simmons, Annalena La Porte, Ambryice M. Riggs, Peter Abbink, Rory T. Coffey, Lauren E. Grandpre, Michael S. Seaman, Gary Landucci, Donald N. Forthal, David C. Montefiori, Angela Carville, Keith G. Mansfield, Menzo J. Havenga, Maria G. Pau, Jaap Goudsmit and Dan H. Barouch

Nature (2008) 457: 87-91; doi:10.1038/nature07469

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

Stephanie C. Eisenbarth, Oscar R. Colegio, William O'Connor, Fayyaz S. Sutterwala and Richard A. Flavell

Nature (2008) 453: 1122-1126; doi:10.1038/nature06939

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

Troy D Querec, Rama S Akondy, Eva K Lee, Weiping Cao, Helder I Nakaya, Dirk Teuwen, Ali Pirani, Kim Gernert, Jiusheng Deng, Bruz Marzolf, Kathleen Kennedy, Haiyan Wu, Soumaya Bennouna, Herold Oluoch, Joseph Miller, Ricardo Z Vencio, Mark Mulligan, Alan Aderem, Rafi Ahmed and Bali Pulendran

Nature Immunology (2008) 10: 116-125; doi:10.1038/ni.1688

Immunity to malaria: more questions than answers

Jean Langhorne, Francis M Ndungu, Anne-Marit Sponaas and Kevin Marsh

Nature Immunology (2008) 9: 725-732; doi:10.1038/ni.f.205

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

Shabaana A Khader, Guy K Bell, John E Pearl, Jeffrey J Fountain, Javier Rangel-Moreno, Garth E Cilley, Fang Shen, Sheri M Eaton, Sarah L Gaffen, Susan L Swain, Richard M Locksley, Laura Haynes, Troy D Randall and Andrea M Cooper

Nature Immunology (2007) 8: 369-377; doi:10.1038/ni1449

MicroRNA-mediated species-specific attenuation of influenza A virus

Jasmine T Perez, Alissa M Pham, Maria H Lorini, Mark A Chua, John Steel and Benjamin R tenOever

Nature Biotechnology (2009) 27: 572-576; doi:10.1038/nbt.1542

Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

David C Chang, Wen J Liu, Itaru Anraku, David C Clark, Christopher C Pollitt, Andreas Suhrbier, Roy A Hall and Alexander A Khromykh

Nature Biotechnology (2008) 26: 571-577; doi:10.1038/nbt1400

Engineered lentivector targeting of dendritic cells for in vivo immunization

Lili Yang, Haiguang Yang, Kendra Rideout, Taehoon Cho, Kye il Joo, Leslie Ziegler, Abigail Elliot, Anthony Walls, Dongzi Yu, David Baltimore and Pin Wang

Nature Biotechnology (2008) 26: 326-334; doi:10.1038/nbt1390

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

Sai T Reddy, André J van der Vlies, Eleonora Simeoni, Veronique Angeli, Gwendalyn J Randolph, Conlin P O'Neil, Leslie K Lee, Melody A Swartz and Jeffrey A Hubbell

Nature Biotechnology (2007) 25: 1159-1164; doi:10.1038/nbt1332

Extra navigation